PATENT CLAIM ANALYSIS

Application Number: 15971017
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "183000"]

Abstract:
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Claim (Index 14):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein R A  is C 1-6  alkyl, CN, OR a1 , C(O)R b1 , C(O)NR c1 R d1 , C(O)OR a1 , and S(O) 2 R b1 ; wherein said C 1-6  alkyl is optionally substituted with 1 substituent selected from R 11 , provided that if R A  is attached to a nitrogen atom, then R A  is not CN or OR a1 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.13793
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15469975', '15234690', '15624850', '15247499', '15151259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8444483507645493
- 35 USC 102 Novelty (BERT): 0.6220124547822441
- Combined Prediction Score: 0.8222047611663187
- Mean Citation Score: 531.0717219999998
- Max Citation Score: 638.51373
- Similarity Product: 518.0485925669145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test